| Pharmaceutical Information |
| Drug Name |
Muromonab-cd3 |
| Drug ID |
BADD_D01506 |
| Description |
Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a). |
| Indications and Usage |
For treatment of organ transplant recipients, prevention of organ rejection |
| Marketing Status |
Not Available |
| ATC Code |
L04AA02 |
| DrugBank ID |
DB00075
|
| KEGG ID |
D05092
|
| MeSH ID |
D016853
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D05GVQ
|
| NDC Product Code |
Not Available |
| Synonyms |
Muromonab-CD3 | Muromonab CD3 | OKT3 | Monoclonal Antibody OKT3 | Orthoclone OKT3 |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
140608-64-6 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
